Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome
Overview
Affiliations
Purpose: The aim of the study was to compare salivary cortisol and α-amylase levels and psychological profiles in patients with burning mouth syndrome (BMS) and healthy subjects.
Methods And Materials: Spitting method was used to collect unstimulated salivary. Salivary cortisol and α-amylase levels were determined using ELISA and the Caraway starch-iodine technique. SLC-90 questionnaire was used to determine the psychological profiles.
Results: The difference between mean of salivary cortisol levels in patients with BMS and in healthy subjects was not significant (4.50 ± 3.68 ng/mL vs. 3.69 ± 3.07 ng/mL, p = 0.377). The difference between mean of α-amylase levels in the BMS patients and healthy subjects was significant (351.68 ± 142.5 and 146.22 ± 130.4, p = 0.001). Note that, 83.4% and 18% of the patients in the case and control groups had psychological problems (p = 0.001).
Conclusion: The results showed higher salivary levels of cortisol and α-amylase in patients with BMS compared to healthy individuals. Psychological problem was prevalent in patients.
Changes in salivary biomarkers of burning mouth syndrome patients after clonazepam treatment.
Jang S, Kim J, Lee Y, Jung W J Oral Facial Pain Headache. 2025; 38(2):111-118.
PMID: 39801101 PMC: 11810660. DOI: 10.22514/jofph.2024.019.
Clinical characteristics and salivary biomarkers of burning mouth syndrome.
Kong M, Kim M, Kim Y, Chang J, Kho H Oral Dis. 2024; 30(8):5360-5369.
PMID: 38622964 PMC: 11610668. DOI: 10.1111/odi.14959.
Glavina A, Lugovic-Mihic L, Martinovic D, Cigic L, Tandara L, Lukenda M Biomedicines. 2023; 11(8).
PMID: 37626679 PMC: 10452894. DOI: 10.3390/biomedicines11082182.
Skrinjar I, Loncar Brzak B, Vidranski V, Vucicevic Boras V, Andabak Rogulj A, Pavelic B Acta Stomatol Croat. 2020; 54(1):44-50.
PMID: 32523156 PMC: 7233125. DOI: 10.15644/asc54/1/5.
Protein-Based Salivary Profiles as Novel Biomarkers for Oral Diseases.
Lorenzo-Pouso A, Perez-Sayans M, Bravo S, Lopez-Jornet P, Garcia-Vence M, Alonso-Sampedro M Dis Markers. 2018; 2018:6141845.
PMID: 30524521 PMC: 6247606. DOI: 10.1155/2018/6141845.